SCHEMBL7976252

SCHEMBL7976252

CCOC(=O)C(Cc1cccc2oc3ccccc3c12)NC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 7/20 0.52
KDM4E B2RXH2 5/20 0.43
MAPT P10636 4/20 0.43
LMNA P02545 3/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
AHR P35869 1/20 0.41
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 2/20 0.40
THRB P10828 1/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
NFKB1 P19838 1/20 0.40
APEX1 P27695 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7962463 0.81 ECE1 (0.53) TACR1KDM4ELMNAHPGDHSD17B10
SCHEMBL27574624 0.76 TACR1 (0.50) TACR1KDM4EMAPTLMNAALDH1A1
SCHEMBL27461720 0.76 TACR1 (0.50) TACR1KDM4EMAPTLMNAALDH1A1
SCHEMBL6379502 0.76 TACR1 (0.50) TACR1KDM4EMAPTLMNAALDH1A1
SCHEMBL16001091 0.76 TACR1 (0.50) TACR1KDM4EMAPTLMNAALDH1A1
SCHEMBL27552215 0.76 TACR1 (0.50) TACR1MAPTLMNAHPGDALDH1A1
SCHEMBL27553428 0.76 TACR1 (0.50) TACR1MAPTLMNAHPGDALDH1A1
SCHEMBL6376795 0.76 TACR1 (0.50) TACR1MAPTLMNAHPGDALDH1A1
SCHEMBL850315 0.74 TACR1 (0.74) TACR1KDM4EMAPTLMNAALDH1A1
SCHEMBL3185689 0.74 TACR1 (0.74) TACR1KDM4EMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001077095-A2 DERIVATIVES OF ALPHA-MERCAPTOACETAMIDE NOVARTIS AG (CH) 2001-10-18 WO disclosed